Skip to main content
NCBI home page
Neurotherapeutics logoLink to Neurotherapeutics
. 2009 Apr;6(2):383–391. doi: 10.1016/j.nurt.2009.01.009

Hormonal therapies: Progesterone

Andrew G Herzog 1,✉
PMCID: PMC5084218  PMID: 19332334

Summary

Seizures do not occur randomly in the majority of people with epilepsy. They tend to cluster. Seizure clusters, in turn, commonly occur with a temporal rhythmicity that shows a readily identifiable and predictable periodicity. When the periodicity of seizure exacerbation in women conforms to that of the menstrual cycle, it is commonly known as catamenial epilepsy. This may be attributable to 1) the neuroactive properties of steroid hormones and 2) the cyclic variation in their serum levels. If hormones play a role in seizure occurrence, hormones may also have a role in treatment. Progesterone has potent GABAergic metabolites that may provide safe and effective seizure control in women who have catamenial epilepsy.

Key Words: Progesterone, epilepsy, catamenial, reproductive, hormones

References

  • 1.Paul SM, Purdy RH. Neuroactive steroids. FASEB J. 1992;6:2311–2322. [PubMed] [Google Scholar]
  • 2.McEwen BS. How do sex and stress hormones affect nerve cells? Ann NY Acad Sci. 1994;743:1–16. doi: 10.1111/j.1749-6632.1994.tb55784.x. [DOI] [PubMed] [Google Scholar]
  • 3.Veíšková J, Velíšek L, Galanopoulou AS, Sperber EF. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia. 2000;41(Suppl 6):S30–S35. doi: 10.1111/j.1528-1157.2000.tb01553.x. [DOI] [PubMed] [Google Scholar]
  • 4.Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 1989;503:354–357. doi: 10.1016/0006-8993(89)91691-0. [DOI] [PubMed] [Google Scholar]
  • 5.Wong M, Moss R. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci. 1992;12:3217–3225. doi: 10.1523/JNEUROSCI.12-08-03217.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kawakami M, Terasawa E, Ibuki T. Changes in multiple unit activity in the brain during the estrous cycle. Neuroendocrinology. 1970;6:30–48. doi: 10.1159/000121900. [DOI] [PubMed] [Google Scholar]
  • 7.Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336:293–306. doi: 10.1002/cne.903360210. [DOI] [PubMed] [Google Scholar]
  • 8.Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-{spd}-aspartate receptor-dependent mechanism. J Neurosci. 1994;14:7680–7687. doi: 10.1523/JNEUROSCI.14-12-07680.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rudick CN, Woolley CS. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci. 2001;21:6532–6543. doi: 10.1523/JNEUROSCI.21-17-06532.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pfaff DW, Keiner M. Estradiol-concentrating cells in the rat amygdala as part of a limbic-hypothalamic hormone-sensitive system. In: Eleftheriou BE, editor. The neurobiology of the amygdala. New York: Plenum Press; 1973. pp. 775–792. [Google Scholar]
  • 11.Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol. 1990;294:76–95. doi: 10.1002/cne.902940107. [DOI] [PubMed] [Google Scholar]
  • 12.McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991;12:141–147. doi: 10.1016/0165-6147(91)90531-V. [DOI] [PubMed] [Google Scholar]
  • 13.Finn DA, Gee KW. The influence of estrus cycle on neurosteroid potency at the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther. 1993;265:1374–1379. [PubMed] [Google Scholar]
  • 14.Wallis CJ, Luttge WG. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J Neurochem. 1980;34:609–613. doi: 10.1111/j.1471-4159.1980.tb11187.x. [DOI] [PubMed] [Google Scholar]
  • 15.Luine VN, Renner KJ, McEwen BS. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments. Endocrinology. 1986;119:874–878. doi: 10.1210/endo-119-2-874. [DOI] [PubMed] [Google Scholar]
  • 16.Terasawa E, Timiras P. Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology. 1968;83:207–216. doi: 10.1210/endo-83-2-207. [DOI] [PubMed] [Google Scholar]
  • 17.Logothetis J, Hamer R. Electrocortical activation by estrogens. Arch Neurol. 1960;3:290–297. doi: 10.1001/archneur.1960.00450030068007. [DOI] [PubMed] [Google Scholar]
  • 18.Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Arch Neurol. 1966;15:521–532. doi: 10.1001/archneur.1966.00470170075008. [DOI] [PubMed] [Google Scholar]
  • 19.Horn AC, Buterbaugh GG. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia. 1986;27:103–108. doi: 10.1111/j.1528-1157.1986.tb03510.x. [DOI] [PubMed] [Google Scholar]
  • 20.Nicoletti F, Speciale C, Sortino MA, et al. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia. 1985;26:252–257. doi: 10.1111/j.1528-1157.1985.tb05414.x. [DOI] [PubMed] [Google Scholar]
  • 21.Spiegel EA, Wycis HT. Anticonvulsant effects of steroids. J Lab Clin Med. 1945;30:947–953. [Google Scholar]
  • 22.Woolley DE, Timiras PS. The gonad-brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology. 1962;70:196–209. doi: 10.1210/endo-70-2-196. [DOI] [PubMed] [Google Scholar]
  • 23.Logothetis J, Hamer R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology. 1959;9:352–360. doi: 10.1212/wnl.9.5.352. [DOI] [PubMed] [Google Scholar]
  • 24.Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia. 2006;47:1447–1451. doi: 10.1111/j.1528-1167.2006.00507.x. [DOI] [PubMed] [Google Scholar]
  • 25.Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232:1004–1007. doi: 10.1126/science.2422758. [DOI] [PubMed] [Google Scholar]
  • 26.Gee KW, McCauley LD, Lan NC. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol. 1995;9:207–227. [PubMed] [Google Scholar]
  • 27.Maguire JL, Stell BM, Rafizadeh M, Mody I. Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci. 2005;8:797–804. doi: 10.1038/nn1469. [DOI] [PubMed] [Google Scholar]
  • 28.Wu FS, Gibbs TT, Farb DH. Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol. 1990;37:597–602. [PubMed] [Google Scholar]
  • 29.Cheney DL, Uzunov D, Costa E, Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3α-hydroxy-5α-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J Neurosci. 1995;15:4641–4650. doi: 10.1523/JNEUROSCI.15-06-04641.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Belelli D, Bolger MB, Gee KW. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol. 1989;166:325–329. doi: 10.1016/0014-2999(89)90077-0. [DOI] [PubMed] [Google Scholar]
  • 31.Kokate TG, Svensson BE, Rogawski MA. Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther. 1994;270:1223–1229. [PubMed] [Google Scholar]
  • 32.Kokate TG, Cohen AL, Karp E, Rogawski MA. Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology. 1996;35:1049–1056. doi: 10.1016/S0028-3908(96)00021-4. [DOI] [PubMed] [Google Scholar]
  • 33.Rhodes ME, Frye CA. Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia. 2004;45:1531–1538. doi: 10.1111/j.0013-9580.2004.16504.x. [DOI] [PubMed] [Google Scholar]
  • 34.Lonsdale D, Nylen K, McIntyre Bumham W. The anticonvulsant effects of progesterone and its metabolites on amygdala-kindled seizures in male rats. Brain Res. 2006;1101:110–116. doi: 10.1016/j.brainres.2006.05.005. [DOI] [PubMed] [Google Scholar]
  • 35.Reddy DS, Castaneda DC, O’Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther. 2004;310:230–239. doi: 10.1124/jpet.104.065268. [DOI] [PubMed] [Google Scholar]
  • 36.Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JMH, Li X. GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature. 1998;392:926–930. doi: 10.1038/31948. [DOI] [PubMed] [Google Scholar]
  • 37.Irwin RP, Maragakis NJ, Rogawski MA, Purdy RH, Farb DH, Paul SM. Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons. Neurosci Lett. 1992;141:30–34. doi: 10.1016/0304-3940(92)90327-4. [DOI] [PubMed] [Google Scholar]
  • 38.Heuser G, Ling GM, Buchwald NA. Sedation or seizures as dose-dependent effects of steroids. Arch Neurol. 1965;13:195–203. doi: 10.1001/archneur.1965.00470020085012. [DOI] [PubMed] [Google Scholar]
  • 39.Levesque LA, Herzog AG, Seibel MM. The effect of phenytoin and carbamazepine on dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J Clin Endocrinol Metab. 1986;63:243–245. doi: 10.1210/jcem-63-1-243. [DOI] [PubMed] [Google Scholar]
  • 40.Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on serum neuroactive steroid concentrations in men with localization-related epilepsy. Epilepsia. 2006;47:1945–1948. doi: 10.1111/j.1528-1167.2006.00826.x. [DOI] [PubMed] [Google Scholar]
  • 41.Phyllis JW. Potentiation of the depression by adenosine of rat cerebral cortex neurones by progestational agents. Br J Pharmacol. 1986;89:693–702. doi: 10.1111/j.1476-5381.1986.tb11173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A. 1992;89:9949–9953. doi: 10.1073/pnas.89.20.9949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hsueh AJW, Peck EJ, Clark JH. Control of uterine estrogen receptor levels by progesterone. Endocrinol. 1976;98:438–444. doi: 10.1210/endo-98-2-438. [DOI] [PubMed] [Google Scholar]
  • 44.Frye CA. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 1995;696:113–120. doi: 10.1016/0006-8993(95)00793-P. [DOI] [PubMed] [Google Scholar]
  • 45.Smith SS, Waterhouse BD, Woodward DJ. Sex steroid effects on extrahypothalamic CNS: II. Progesterone, alone and in combination with estrogen, modulates cerebellar responses to amino acid neurotransmitters. Brain Res. 1987;422:52–62. doi: 10.1016/0006-8993(87)90539-7. [DOI] [PubMed] [Google Scholar]
  • 46.Landgren S, Bäckström T, Kalistratov G. The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat’s cerebral cortex. J Neurol Sci. 1978;36:119–133. doi: 10.1016/0022-510X(78)90166-1. [DOI] [PubMed] [Google Scholar]
  • 47.Hoffman GE, Moore N, Fiskum G, Murphy AZ. Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol. 2003;182:124–134. doi: 10.1016/S0014-4886(03)00104-3. [DOI] [PubMed] [Google Scholar]
  • 48.Bäckström T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand. 1984;69:240–248. doi: 10.1111/j.1600-0404.1984.tb07807.x. [DOI] [PubMed] [Google Scholar]
  • 49.Taubøll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res. 1991;8:153–165. doi: 10.1016/0920-1211(91)90084-S. [DOI] [PubMed] [Google Scholar]
  • 50.Fowler K, Massaro J, Harden C, et al. Distribution of seizure occurrence in women with epilepsy: preliminary data analysis in a prospective multicenter investigation. Epilepsia. 2006;47(Suppl 4):1–1. [Google Scholar]
  • 51.Almqvist R. The rhythm of epileptic attacks and its relationship to the menstrual cycle. Acta Psychiatr Neurol Scand Suppl. 1955;105:1–116. [PubMed] [Google Scholar]
  • 52.Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia. 1997;38:1082–1088. doi: 10.1111/j.1528-1157.1997.tb01197.x. [DOI] [PubMed] [Google Scholar]
  • 53.Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 2004;56:431–434. doi: 10.1002/ana.20214. [DOI] [PubMed] [Google Scholar]
  • 54.Quigg M, Fowler KM, Herzog AG, NIH Progesterone Trial Study Group Circalunar and ultralunar periodicities in women with partial seizures. Epilepsia. 2008;49:1081–1085. doi: 10.1111/j.1528-1167.2008.01537.x. [DOI] [PubMed] [Google Scholar]
  • 55.Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976;54:321–347. doi: 10.1111/j.1600-0404.1976.tb04363.x. [DOI] [PubMed] [Google Scholar]
  • 56.Laidlaw J. Catamenial epilepsy. Lancet. 1956;271:1235–1237. doi: 10.1016/S0140-6736(56)90003-4. [DOI] [PubMed] [Google Scholar]
  • 57.Herzog AG, Fowler KM, NIH Progesterone Trial Study Group Sensitivity and specificity of the association between catamenial seizure patterns and ovulation. Neurology. 2008;70:486–487. doi: 10.1212/01.wnl.0000278102.55701.d0. [DOI] [PubMed] [Google Scholar]
  • 58.Dana-Haeri J, Richens A. Effect of norethisterone on seizures associated with menstruation. Epilepsia. 1983;24:377–381. doi: 10.1111/j.1528-1157.1983.tb04901.x. [DOI] [PubMed] [Google Scholar]
  • 59.Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology. 1984;34:1255–1258. doi: 10.1212/wnl.34.9.1255. [DOI] [PubMed] [Google Scholar]
  • 60.Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology. 1986;36:1607–1610. doi: 10.1212/wnl.36.12.1607. [DOI] [PubMed] [Google Scholar]
  • 61.Herzog AG. Progesterone therapy in complex partial and secondary generalized seizures. Neurology. 1995;45:1660–1662. doi: 10.1212/wnl.45.9.1660. [DOI] [PubMed] [Google Scholar]
  • 62.Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology. 1999;52:1917–1918. doi: 10.1212/wnl.52.9.1917-a. [DOI] [PubMed] [Google Scholar]
  • 63.Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol. 2003;53:390–391. doi: 10.1002/ana.10508. [DOI] [PubMed] [Google Scholar]
  • 64.Herzog AG, Friedman MN, Freund S, Pascual-Leone A. Transcranial magnetic stimulation evidence of a potential role for progesterone in the modulation of premenstrual corticocortical inhibition in a woman with catamenial seizure exacerbation. Epilepsy Behav. 2001;2:367–369. doi: 10.1006/ebeh.2001.0232. [DOI] [PubMed] [Google Scholar]
  • 65.Zimmerman AW, Holden KR, Reiter EO, Dekaban AS. Medroxy-progesterone acetate in the treatment of seizures associated with menstruation. J Pediatr. 1973;83:959–963. doi: 10.1016/S0022-3476(73)80529-3. [DOI] [PubMed] [Google Scholar]
  • 66.Hall SM. Treatment of menstrual epilepsy with a progesteroneonly oral contraceptive. Epilepsia. 1977;18:235–236. doi: 10.1111/j.1528-1157.1977.tb04471.x. [DOI] [PubMed] [Google Scholar]
  • 67.Bauer J, Wildt L, Flügel D, Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol. 1992;239:284–286. doi: 10.1007/BF00833921. [DOI] [PubMed] [Google Scholar]
  • 68.Haider Y, Bamett DB. Catamenial epilepsy and goserelin. Lancet. 1991;338:1530–1530. doi: 10.1016/0140-6736(91)92354-5. [DOI] [PubMed] [Google Scholar]
  • 69.Reid B, Gangar KF. Catamenial epilepsy and goserelin. Lancet. 1992;339:253–253. doi: 10.1016/0140-6736(92)90066-C. [DOI] [PubMed] [Google Scholar]
  • 70.Finkelstein JS, Klibanski A, Schaefer EH, Homstein MD, Schiff I, Neer RM. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med. 1994;331:1618–1623. doi: 10.1056/NEJM199412153312404. [DOI] [PubMed] [Google Scholar]
  • 71.Herzog AG. Reproductive endocrine considerations and hormonal therapy for women with epilepsy. Epilepsia. 1991;32(Suppl 6):S27–S33. doi: 10.1111/j.1528-1157.1991.tb05889.x. [DOI] [PubMed] [Google Scholar]

Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES